Blog
Get the latest news about liver diseases and more
Get the latest news about liver diseases and more
Infliximab shows positive results in autoimmune hepatitis resistant to conventional therapies, improving liver function in most patients and representing a potential future treatment option.
Women with early menarche show a higher risk of fatty liver disease. Later onset lowers this risk, highlighting the importance of monitoring weight and liver health.
MariTide, a new drug for obesity, delivers significant weight loss with a single monthly injection, while also reducing blood pressure and glucose levels in patients.
A study links elevated blood manganese levels with a higher risk of liver disease. Controlling dietary intake and workplace exposure is crucial to reduce this risk and protect health.
A comparative study found that tirzepatide outperforms semaglutide for weight loss, achieving greater reductions in body weight, waist circumference, and blood pressure, with similar side effects in both treatments.
Linerixibat, a bile acid transport inhibitor, has shown significant benefits in the treatment of pruritus in primary biliary cholangitis, reducing itching and improving sleep with minimal side effects.
A promising new treatment for fatty liver disease has outperformed existing medications like Ozempic and Mounjaro in reducing liver fat, according to a recent study presented at a major liver disease conference.
Hepalatide, used with pegylated interferon-alpha, shows promise for curing chronic hepatitis B by eliminating cccDNA from liver cells, according to early study results presented in a European liver congress.
23 de August de 2018
15 de August de 2020
26 de June de 2022